Jazz took a step forward with the Chimerix acquisition that should further diversify its revenue base. Read why JAZZ stock is ...

When it comes to investing, there are some useful financial metrics that can warn us when a business is potentially ...

The Alice Cooper Band's outrageous behaviour prompted a statement in Parliament while their songs thrilled a generation ...

Tempus AI, Inc. is revolutionizing healthcare genomics with AI and data partnerships. Click here to read an analysis on TEM ...

Large-scale, multi-country real-world evidence (RWE) studies—including in Central Nervous System (CNS) indications—have the ...

Well, thank you, and I'm not going to give the written remarks. I'm just going to sort of walk you through this a little bit. That's ...

Vertex Pharmaceuticals should have big winners with pain drug Journavx and two promising pipeline candidates. Summit ...

A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy for B-cell acute lymphoblastic leukemia (B-ALL), the commonest cancer in childhood and one that can be ...

The U.S. In Vitro Diagnostics (IVD) and Laboratory-Developed Tests (LDT) market for autoimmune diseases is set to witness transformative growth over the next decade. Valued at USD 2.51 billion in 2023 ...

Repeated positive recommendation from Data Safety Monitoring Board ("DSMB") of pivotal Phase 3 study for lead clinical ...

ORION CORPORATION INVESTOR NEWS 21 MAY 2025 at 07.30 EEST Orion's collaborator, MSD, expands clinical development program for opevesostat to women's cancers Orion's collaborator, ...

The global demineralized bone matrix (DBM) market is experiencing sustained expansion as it solidifies its role as a vital component in orthopedic and regenerative medicine. Valued at USD 1.83 billion ...